Ro CEO on increased demand for GLP-1 pill, and decreased prices

The demand for the pill is beyond what anyone expected. We expected it to be tremendous and it's an order of magnitude more than that and it's really been incredible and I think it's because with this product you have a better form factor for many people. It's more approachable. It's more affordable.18 months ago they were only approved for diabetes and obesity. 18 months ago they were also $1,300. Now the starting price is$149.Right. So the initial price has come down 80 90%. And the efficacy is there whic ...